These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11455002)
21. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775 [TBL] [Abstract][Full Text] [Related]
22. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Bhattacharya B; Dilworth HP; Iacobuzio-Donahue C; Ricci F; Weber K; Furlong MA; Fisher C; Montgomery E Am J Surg Pathol; 2005 May; 29(5):653-9. PubMed ID: 15832090 [TBL] [Abstract][Full Text] [Related]
23. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Coffin CM; Hornick JL; Zhou H; Fletcher CD Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483 [TBL] [Abstract][Full Text] [Related]
25. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929 [TBL] [Abstract][Full Text] [Related]
26. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hauben EI; Jundt G; Cleton-Jansen AM; Yavas A; Kroon HM; Van Marck E; Hogendoorn PC Hum Pathol; 2005 Sep; 36(9):1025-30. PubMed ID: 16153468 [TBL] [Abstract][Full Text] [Related]
28. Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation. Bläker H; Scholten M; Sutter C; Otto HF; Penzel R Am J Clin Pathol; 2003 Sep; 120(3):418-23. PubMed ID: 14502807 [TBL] [Abstract][Full Text] [Related]
29. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787 [TBL] [Abstract][Full Text] [Related]
30. Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis. Miller DV; Wang H; Wang H; Fealey ME; Tazelaar HD Pediatr Dev Pathol; 2008; 11(4):291-4. PubMed ID: 18078366 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Carlson JW; Fletcher CD Histopathology; 2007 Oct; 51(4):509-14. PubMed ID: 17711447 [TBL] [Abstract][Full Text] [Related]
32. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas. Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714 [TBL] [Abstract][Full Text] [Related]
33. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582 [TBL] [Abstract][Full Text] [Related]
35. APC mutations are infrequent but present in human lung cancer. Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328 [TBL] [Abstract][Full Text] [Related]
37. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer. Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741 [TBL] [Abstract][Full Text] [Related]
38. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Chen YW; Jeng YM; Yeh SH; Chen PJ Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840 [TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Shinohara A; Yokoyama Y; Wan X; Takahashi Y; Mori Y; Takami T; Shimokawa K; Tamaya T Gynecol Oncol; 2001 Sep; 82(3):450-5. PubMed ID: 11520139 [TBL] [Abstract][Full Text] [Related]
40. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene. Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]